Good day, everyone, and welcome to today's Q4 2024 Transocean Earnings Call. [Operator Instructions] Please note, today's conference is being recorded. I will be standing by if you should need any ...

Operator Good day, everyone, and welcome to today's Q4 2024 Transocean earnings call. [Operator instructions] Please note today's conference is being recorded. I will be standing by if you should need ...

Wall Street is mining a new treasure trove of assets: The savings built up in Japanese life insurance. Companies controlled by KKR & Co., Apollo Global Management Inc. and other giant investors ...

which has driven up our ARPOB and has also aided us in our Ebitda expansion," Madhu Sasidhar, president and CEO of the hospitals division, told Mint. Apollo reported an 8% year-on-year increase to ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

The revenues of the quarter were at ₹4,850.6 crore for the same period last year, which catapulted up by 13.9% YoY ... of the face value of ₹5, for the FY 2024-25. Apollo Hospitals are seeing ...

Stocks to buy for long term: After six days of losses, the Indian stock market staged a relief rally on Thursday, February 13, pushing the benchmark indices—the Sensex and the Nifty 50—up by ...

On this date, Jan. 22, 1968, Apollo 5 launched in a major step forward for U.S. missions to the lunar surface. The Apollo 5 mission tested the Lunar Module in space for the first time, which was ...

Apollo heard his final call Wednesday after working for about two-and-a-half years. Before that, he spent four years with the Nelson County Sheriff's Department. In his time on the street ...

Apollo Global Management Inc. is also among firms ... Diameter Capital Partners and Darsana Capital Partners were among firms that snapped up a major part of that sale, according to people with ...

Gilead will buy Nimbus Therapeutics' liver drug subsidiary Nimbus Apollo in a $1.2 billion deal. The acquisition of Nimbus' lead ACC inhibitor - which would treat a major cause of NASH - could ...